-
TD Cowen Reiterates Buy Rating on Cellebrite (CLBT)
-
Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c
-
DOJ to sponsor Cellebrite for FedRAMP authorization
-
Cellebrite DI Ltd. (CLBT) call put ratio 1 call to 5.3 puts with a focus on 1K contracts of July 15 puts
-
Cellebrite names David Barter as CFO, Dana Gerner to retire
-
Cellebrite (CLBT) to Acquire Corellium
-
Agios Pharma (AGIO) BofA Makes Changes to Endeavor List
-
Cellebrite DI Ltd. (CLBT) Tops Q4 EPS by 4c
-
Cellebrite DI Ltd. (CLBT) call put ratio 1 call to 7.6 puts with a focus on February 22.50 puts
-
Cellebrite (CLBT) PT Raised to $28 at JPMorgan
-
Cellebrite (CLBT) PT Raised to $28 at Needham
-
Cellebrite DI Ltd. (CLBT) Tops Q3 EPS by 7c, provides guidance
-
Cellebrite (CLBT) PT Raised to $23 at Craig-Hallum
-
Cellebrite (CLBT) PT Raised to $23 at TD Cowen
-
Cellebrite DI Ltd. (CLBT) Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
-
Cellebrite (CLBT) PT Raised to $17 at Lake Street Capital Markets
-
Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 6c, Offers Guidance
-
Cellebrite DI Ltd. (CLBT) Announces Redemption of All Outstanding Warrants
-
Cellebrite DI Ltd. (CLBT) Appoints Troy K. Richardson to its Board
-
Cellebrite (CLBT) PT Raised to $15 at JPMorgan
-
Cellebrite DI Ltd. (CLBT) Appoints Sigalit Shavit as Chief Information Officer
-
Cellebrite DI Ltd. (CLBT) to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
-
Cellebrite DI Ltd. (CLBT) July 10 calls active as share price up 10%

